학술논문

Pharmacotherapy of Epileptic Seizures in Glioma Patients: Who, When, Why and How Long?
Document Type
Academic Journal
Source
Onkologie. Aug 01, 2005 28(8):391-396
Subject
Language
English
ISSN
0378-584X
Abstract
BACKGROUND:: The risk for patients with primary brain tumors of experiencing an epileptic seizure at least once in the course of disease probably exceeds 50%, depending on tumor location and tumor type. Several aspects regarding the role of anticonvulsants in the treatment of brain tumor patients have remained controversial. PATIENTS AND METHODS:: We reviewed the seizure history in 107 patients undergoing a surgical procedure for glioma at our institution. RESULTS:: The overall seizure incidence was 68%. Pre-operative seizures did not predict the occurrence of post-operative seizures. After surgery, postoperative chemo- or radiotherapy and anticonvulsive therapy one third of patients was seizure-free whereas one third showed frequent seizures despite this treatment. Seizure frequency increased regardless of anticonvulsive treatment with progressive or recurrent tumor growth. CONCLUSIONS:: Based on a literature review and our institutional experience, we delineate some recommendations for the management of seizures in patients with brain tumors.